A biopharmaceutical company that purchases royalties from drug developers and funds innovation in the biopharmaceutical industry. The company's portfolio includes royalties on marketed therapies and development-stage product candidates across therapeutic areas such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes.